Trials / Completed
CompletedNCT01660737
Observational Study With PASCALLERG ® in Patients With Hay Fever
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 123 (actual)
- Sponsor
- Pascoe Pharmazeutische Praeparate GmbH · Industry
- Sex
- All
- Age
- 1 Year
- Healthy volunteers
- Not accepted
Summary
The aim of this observational study is to document the therapeutic use of PASCALLERG ® for hay fever. Based on the survey is a decrease in disease-specific symptoms when taking PASCALLERG ® over a period of 4 weeks will be documented. In addition to the compatibility can be assessed.
Detailed description
There are documented male and female patients over the age of one year who suffer from hay fever. The traetment time is about a period of 4 weeks with PASCALLERG® tablets.
Conditions
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2012-08-09
- Last updated
- 2021-03-30
- Results posted
- 2017-06-19
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01660737. Inclusion in this directory is not an endorsement.